Psychiatric Neurosurgery with Advanced Imaging and Deep Brain Stimulation Techniques

  • Amirhossein Rahmani Department of Plastic and Reconstructive Surgery, Iranshahr University of Medical Sciences, Iranshahr, Iran.
  • Faezeh Norouzi Psychiatry and Behavioral Science, Isfahan University of Medical Science, Isfahan, Iran.
  • Bruna Lino Modes Santos Machado Instituto Luterano de Ensino Superior de Itumbiara, Brazil.
  • Fariba Ghasemi Islamic Azad University, Tehran, Iran.
Keywords: Deep Brain Stimulation, Neurosurgery, Obsessive-compulsive Disorder, Treatment-resistant Depression, Tractography

Abstract

This study aims to reevaluate key research on the application of advanced neuroimaging techniques for enhancing deep brain stimulation (DBS) targeting psychiatric disorders. A comprehensive review of PubMed publications was conducted, focusing on psychiatric neurosurgery, DBS, diffusion tensor imaging, probabilistic tractography, functional magnetic resonance imaging (fMRI), and blood oxygen level-dependent activation. Relevant studies were included for analysis. Recent advancements in neuroimaging, such as probabilistic tractography, diffusion tensor imaging, functional MRI, and positron emission tomography (PET), have provided higher-resolution characterizations of structural and functional connectivity within areas of interest. These imaging methods have improved our understanding of DBS mechanisms, moving from a single-system approach to more complex network-based targeting. This progress has enabled the discovery of new DBS targets and allowed for more personalized approaches to treating psychiatric conditions. Advanced neuroimaging techniques may be crucial for individualized DBS targeting disorders like treatment-resistant depression and obsessive-compulsive disorder, where disease manifestations and underlying causes are highly variable. These findings suggest cutting-edge imaging can further personalize and optimize DBS, enhancing its overall effectiveness in psychiatric neurosurgery.

References

Scangos KW, State MW, Miller AH, Baker JT, Williams LM. New and emerging approaches to treat psychiatric disorders. Nature medicine. 2023 Feb;29(2):317-33. doi: https://doi.org/10.1038/s41591-022-02197-0

Cox SS, Connolly DJ, Peng X, Badran BW. A Comprehensive Review of Low-Intensity Focused Ultrasound Parameters and Applications in Neurologic and Psychiatric Disorders. Neuromodulation: Technology at the Neural Interface. 2024 Sep 4. doi: https://doi.org/10.1016/j.neurom.2024.07.008

Norouzi F, Machado BL, Ghasemi F, Alvani MS. Data-Driven Analysis of Psychiatric Disorders in Type 2 Diabetic Patients and Associations with Demographic Factors. International Journal of Applied Data Science in Engineering and Health. 2024 Oct 8;1(2):49-56. https://ijadseh.com/index.php/ijadseh/article/view/14

Tanaka M, Vécsei L. From lab to life: Exploring cutting-edge models for neurological and psychiatric disorders. Biomedicines. 2024 Mar 8;12(3):613. doi: https://doi.org/10.3390/biomedicines12030613

Ghasemi Y, Afrazeh F, Shomalzadeh M, Rostamian S, Abbasi H. Recent updates on the safety of neurosurgery during the COVID-19 pandemic. World Journal of Biology Pharmacy and Health Sciences. 2024;19(1):018-23; doi: https://doi.org/10.30574/wjbphs.2024.19.1.0389

Chancler C, Anderson HD. Neurologic and Neurosurgical Diseases and Disorders. InAcute Care Physical Therapy 2024 Jun 1 (pp. 351-420). Routledge. doi: https://doi.org/10.30574/wjbphs.2024.19.1.0389

Duggineny S. Neurological Disorders: A Comprehensive Review of Insights and Innovations in Treatment Development. Unique Endeavor in Business & Social Sciences. 2023 Jun 30;2(1):28-36.

Afrazeh F, Ghasemi Y, Abbasi H, Rostamian S, Shomalzadeh M. Neurological Findings Associated with Neuroimaging in COVID-19 Patients: A Systematic Review. International Research in Medical and Health Sciences. 2024 Jul 30;7(3):1-5. doi: https://doi.org/10.36437/irmhs.2024.7.3.A

Sun N, Lou P, Shang Y, Zhang P, Wang J, Chang G, Shi C. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open. 2016;6(8); doi: https://doi.org/10.1136/bmjopen-2016-012540

Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49. doi: https://doi.org/10.1016/j.diabres.2013.11.002

Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002 Dec;53(6):1053–60. doi: https://doi.org/10.1016/s0022-3999(02)00417-8

Mirzaei M, Daryafti H, Fallahzadeh H, Azizi B. Evaluation of Depression, Anxiety and Stress in Diabetic and Non-Diabetic Patients. JSSU. 2016;24(5):387-97. https://jssu.ssu.ac.ir/browse.php?a_code=A-10-2567-1&slc_lang=en&sid=1

Egede LE, Dismuke CE. Serious Psychological Distress and Diabetes: A Review of the Literature. Curr Psychiatry Rep. 2012;14:15–22. doi: https://doi.org/10.1007/s11920-011-0240-0

Robinson N, Fuller JH, Edmeades SP. Depression and diabetes. Diabetic Medicine. 1988 Apr;5(3):268-74. doi: https://doi.org/10.1111/j.1464-5491.1988.tb00983.x

Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther. 1997;35:79-89. doi: https://doi.org/10.1016/s0005-7967(96)00068-x

Clara IP, Cox BJ, Enns MW. Confirmatory factor analysis of the Depression-Anxiety-Stress Scales in depressed and anxious patients. J Psychopathol Behav Assess. 2001;23:61-7.

Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44:227-39. doi: https://doi.org/10.1348/014466505x29657

Taheri N, Hojjati H, Mousavi M, Afra A, Dehghan B. The Survey of Anxiety and Depression Prevalence in Diabetic Patients Referred to Abadan Taleghani and Khorramshahr Valiasr Hospitals. JDN. 2011;1(2):21-31. https://jdn.zbmu.ac.ir/browse.php?a_id=36&sid=1&slc_lang=en

Asad Abadi A, Aziz Zadeh Foroozi M, Fuladvandi GR, Fuladvandi M, Lashkari T, Malekian L. Effectiveness of stress management training on improved quality of life in patients with type 2 diabetes. JHPM. 2014;2(3):16-24. http://jhpm.ir/article-1-282-en.html

Esmaili A, Asadnia S, Easazadeh A, Amirsardari L, Issazadeghan A, Ansari B. Evaluation of the effectiveness of cognitive behavioral therapy on decreasing depression levels and improving the lifestyle of patients with type 2 diabetes. Urmia Med J. 2013;24(10):822. http://umj.umsu.ac.ir/article-1-1991-en.html

Ranjbar Kh, Sharif F, Dzhbkhsh T. Frequency and severity of depression in diabetic adults using tablet and insulin. HMJ. 2006;10(4):363-9. https://ijadseh.com/index.php/ijadseh/article/view/14

Moayedi F, Zare S, Nikbakht A. Anxiety and depression in diabetic patients referred to Bandar Abbas diabetes clinic. HMJ. 2012;18(1):65-71. https://hmj.hums.ac.ir/Article/87848

Attari A, Mehrabi A, Davazdah Emamy MH, Roshan R. The Effectiveness of Cognitive-Behavioral Stress Management Training on Glycemic Control and Depression in Patients with Type 2 Diabetes. IJEM. 2009;11(4):385-92. https://ijem.sbmu.ac.ir/browse.php?a_id=854&sid=1&slc_lang=en

Ansari M, Shams Sfandabad H, Hakami M. The effect of training anger control and stress management on blood glucose levels in people with diabetes. HPJ. 2011;1(3):47-60.

Zahrakar K. A Study of Effectiveness of Group-based Rational, Emotive, Behavior Therapy (REBT) on Decrease of Stress among Diabetic Patients. JKH. 2012;7(4):160-4.

Amiri M, Aghaei A, Abedi A, Safari Y. Effectiveness of stress inoculation training (SIT) on depression in diabetics. HPJ. 2014;3(1):16-28.

Mahmoodi GH, Abolghasemi SH, Darvishi H. The effect of stress inoculation training on reducing psychological pressure in patients with type 2 diabetes. JHB. 2012;2(2):41-4.

Alhani F, Mohajeri Tehrani MR, Sharifirad G, Shojaeezadeh D, Tol A. Effect of empowerment model on distress and diabetes control in patients with type 2 diabetes. JNE. 2012;1(1):38-47. https://jne.ir/article-1-51-en.html

Zare S, Nikbakht A, Moayedi F. Anxiety and depression in diabetic patients referred to Bandar Abbas diabetes clinic. HMJ. 2014;18(1):65-71. https://hmj.hums.ac.ir/Article/87848

Mehrabi A, Fata L, Davazdah Emami MH, Rajab A. Effect of stress management training based on cognitive-behavioral theory on glycemic control and reduction of emotional problems in patients with type 1 diabetes. IJEM. 2008;8(2):103-14.

Khosravi A, Aghayan Sh, Mousavi SA, Razavian–zade N, Norouzi N. Depression and General Health Status in Type II Diabetic Patients. JKH. 2008;3(1):44-8. https://www.magiran.com/paper/606825/depression-and-general-health-status-in-type-ii-diabetic-patients?lang=en

Sayehmiri K, Sheykhi A, Rabiei Fakhr F, Yadegarazadi A, Azami M. The prevalence of depression in patients with type 2 diabetes in Iran - systematic review and meta-analysis study. IJEM. 2016;15(4):217-24.

Park CY, Kim SY, Gil JW, Park MH, Park JH, Kim Y. Depression among Korean adults with Type 2 Diabetes Mellitus: Ansan-Community-based Epidemiological Study. PHRP. 2015;6(4):224-32. doi: https://doi.org/10.1016/j.phrp.2015.05.004

Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample: Results from the German National Health Interview and Examination Survey. JDC. 2003;26(6):1841-6. doi: https://doi.org/10.2337/diacare.26.6.1841

Ferreira MC, Piaia C, Cadore AC, Antoniolli MA, Gamborgi GP, Oliveira PP. Clinical variables associated with depression in patients with type 2 diabetes. Revista da Assoc Med Brasileira (1992). 2015;61(4):336-40. doi: https://doi.org/10.1590/1806-9282.61.04.336

Taherian M, Tajabadi Z, Azhideh A, Taherian R. Methotrexate-induced neurocognitive late effects in treatment of pediatric acute lymphoblastic leukemia: a review. Human, Health and Halal Metrics. 2021 Oct 5;2(1):63-74. doi: https://doi.org/10.30502/jhhhm.2021.283539.1031

Mirzaei A, Mohammadi S, Mazloomy SS. Study of depression prevalence in the patients with type II diabetes referring to Yazd Diabetes Research Centers in 2008. TBJ. 2008;7(1-2):30-5. doi: https://doi.org/10.4103/0253-7176.119502

Radpour A, Bahrami-Motlagh H, Taaghi MT, Sedaghat A, Karimi MA, Hekmatnia A, Haghighatkhah HR, Sanei-Taheri M, Arab-Ahmadi M, Azhideh A. COVID-19 evaluation by low-dose high resolution CT scans protocol. Academic Radiology. 2020 Jun;27(6):901. doi: https://doi.org/10.1016/j.acra.2020.04.016

Arefi Shirvan R, Setaredan SK, Motie Nasrabadi A. Classification of mental stress levels by analyzing fNIRS signals using linear and non-linear features. 2018;5(2):55-61. https://journals.sbmu.ac.ir/neuroscience/article/view/21016

Kasiri Dolat Abadi N, Mortezapour S, Hosseini M. Depression in diabetes patients with type 2, Isfahan, Iran. J Health System Res. 2010;6(2):308-14. https://hsr.mui.ac.ir/browse.php?a_id=129&sid=1&slc_lang=en

Taherian M, Tajabadi Z, Azhideh A, Taherian R. Methotrexate-induced neurocognitive late effects in treatment of pediatric acute lymphoblastic leukemia: a review. Human, Health and Halal Metrics. 2021 Oct 5;2(1):63-74. doi: https://doi.org/10.30502/jhhhm.2021.283539.1031

Ashrafi F, Rezaei A, Azhideh A, Tabeie F, Gachkar L, Ahmadi MA, Yousefi-Asl M, Zali A, Khoshnoud RJ. Effectiveness of Extremely Low Frequency Electromagnetic Field and Pulsed Low Level Laser Therapy in Acute Stroke Treatment. International Clinical Neuroscience Journal. 2020 Jul 1;7(3):127. https://journals.sbmu.ac.ir/neuroscience/article/view/29304

Mikaliukstiene A, Zagminas K, Juozulynas A, Narkauskaite L, Salyga J, Jankauskiene K, et al. Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monitor: Inter Med J Experiment Clinic Res. 2014;20:182-90. doi: https://doi.org/10.12659/msm.890019

Radpour A, Bahrami-Motlagh H, Taaghi MT, Sedaghat A, Karimi MA, Hekmatnia A, Haghighatkhah HR, Sanei-Taheri M, Arab-Ahmadi M, Azhideh A. COVID-19 evaluation by low-dose high resolution CT scans protocol. Academic Radiology. 2020 Jun;27(6):901. doi: https://doi.org/10.1016/j.acra.2020.04.016

Mirzaei A, Mohammadi S, Mazloomy SS. Study of depression prevalence in patients with type II diabetes referring to Yazd Diabetes Research Centers in 2008. TBJ. 2008;7(1-2):30-5.

Park CY, Kim SY, Gil JW, Park MH, Park JH, Kim Y. Depression among Korean adults with Type 2 Diabetes Mellitus: Ansan-Community-based Epidemiological Study. PHRP. 2015;6(4):224-32. doi: https://doi.org/10.1016/j.phrp.2015.05.004

Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample: Results from the German National Health Interview and Examination Survey. JDC. 2003;26(6):1841-6. doi: https://doi.org/10.2337/diacare.26.6.1841

Published
2024-11-01
How to Cite
Rahmani, A., Norouzi, F., Santos Machado, B. L. M., & Ghasemi, F. (2024). Psychiatric Neurosurgery with Advanced Imaging and Deep Brain Stimulation Techniques. International Research in Medical and Health Sciences, 7(5), 63-74. https://doi.org/10.36437/irmhs.2024.7.5.F